Q2 2026 Holdings
Filed 2026-08-13 | 9 holdings | $47.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $26.7M | 4,588,284 | 56.5% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $8.1M | 9,248,250 | 17.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $4.9M | 88,354 | 10.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $3.0M | 36,851 | 6.4% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $1.5M | 1,856,117 | 3.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.1M | 599,793 | 2.4% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $1.1M | 101,203 | 2.4% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $721.2K | 210,871 | 1.5% |
| Curis Inc(CRIS) | COM | 231269309 | $148.7K | 284,889 | 0.3% |